Efficacy and safety of teneligliptin, a dipeptidyl peptidase-4 inhibitor, combined with metformin in Korean patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled phase III trial
替格列汀(一种二肽基肽酶-4抑制剂)联合二甲双胍治疗韩国2型糖尿病患者的疗效和安全性:一项为期16周的随机、双盲、安慰剂对照III期临床试验
期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.12424
Kim, M K; Rhee, E-J; Han, K A; Woo, A C; Lee, M-K; Ku, B J; Chung, C H; Kim, K-A; Lee, H W; Park, I B; Park, J Y; Chul Jang, H C; Park, K S; Jang, W I; Cha, B Y